Company Milestone

time line

2015

In November, PersonGen received capital investment from Anhui Anke Biotechnology (Group) Co., Ltd.

In November, PersonGen launched the world's first clinical trial of a MUC1-CAR-T cell products for solid tumors.

In July, PersonGen won the Advanced Technology Service Enterprise.

In March, PersonGen launched the world's first clinical trial of a multi-target CAR-NK cell product.